Save Search

Note: Where available, the PDF/Word icon below is provided to view the complete and fully formatted document
Veterans’ Affairs Legislation Amendment Bill 2012

Bill home page  


Download WordDownload Word


Download PDFDownload PDF

7355 REVISED

2010-2011-2012-2013

 

The Parliament of the

Commonwealth of Australia

 

THE SENATE

 

 

 

 

Veterans’ Affairs Legislation Amendment Bill 2012

 

 

(1)           Clause 2, page 2 (after table item 4), insert:

5.  Schedule 2

The day the Veterans’ Affairs Legislation Amendment Act 2012 receives the Royal Assent.

 

[nuclear tests]

(2)     Page 13 (after line 27), at the end of the Bill, add:

 

Schedule 2 —Further a mendments

Australian Participants in British Nuclear Tests (Treatment) Act 2006

1  At the end of the Act

Add:

51  Provision of information about nuclear test participants

             (1)  The Minister must cause to be made available to the Parliament answers to the following questions:

                     (a)  whether the support provided to nuclear test participants pursuant to this Act is sufficient; and

                     (b)  whether the meaning of nuclear test area in section 4 is wide enough to cover all persons impacted by nuclear tests carried out in Australia; and

                     (c)  whether, taking into account the age and medical condition of nuclear test participants, it is appropriate to institute an expedited procedure for making claims under this Act; and

                     (d)  why the nuclear test areas referred to in section 5(4) are limited to:

                              (i)  within 10 kilometres of Main Beach on Trimouille Island in the Monte Bello Archipelago; and

                             (ii)  within 25 kilometres of the Totem test sites at Emu Field; and

                            (iii)  within 40 kilometres of any of the Buffalo or Antler test sites; and

                     (e)  information about the number and types of claimants who have made a claim under the Act, but were determined not to be covered by the Act because they were located outside the nuclear test areas; and

                      (f)  information about the types of illnesses, diseases and maladies suffered by claimants who have made a claim under the Act, but were determined not to be covered by the Act; and

                     (g)  whether the Act provides support for nuclear test participants suffering from the following illnesses, diseases and maladies:

                              (i)  cancer (wherever occurring) or malignant neoplasia;

                             (ii)  leukaemia;

                            (iii)  lymphoma;

                            (iv)  myeloma (whether multiple or singular);

                             (v)  non-malignant thyroid nodular disease;

                            (vi)  parathyroid adenoma;

                           (vii)  posterior subscapular cataracts;

                          (viii)  tumours of the brain and/or central nervous system;

                            (ix)  ulceration of the skin;

                             (x)  sarcoma;

                            (xi)  malignant overgrowth of the blood;

                           (xii)  fibrosis of the lung;

                          (xiii)  lung cancer;

                          (xiv)  sterility (whether temporary or permanent);

                           (xv)  reduced fertility (whether temporary or permanent);

                          (xvi)  cell scarring of the thyroid, liver or intestine;

                         (xvii)  loss of function of the thyroid, liver or intestine;

                        (xviii)  loss of function or breakdown of intestinal lining;

                          (xix)  cell death or malignant changes;

                           (xx)  internal bleeding;

                          (xxi)  reduction of lymphoid cells in blood;

                         (xxii)  overgrowth of lymph tissues;

                        (xxiii)  cirrhosis of the liver;

                        (xxiv)  psychological illness of any kind;

                         (xxv)  any similar illness, disease or malady; and

                     (h)  whether the list of illnesses, diseases and maladies covered by the Act should be extended to cover other kinds of illnesses, diseases and maladies.

             (2)  The Minister must ensure that the written answers referred to in subsection (1) are prepared in such a way that:

                     (a)  personal information about claimants and nuclear test participants is not disclosed; and

                     (b)  the privacy of claimants and nuclear test participants is protected.

             (3)  The Minister must do each of the following by 26 June 2013:

                     (a)  make the answers to the questions in subsection (1) publicly available; and

                     (b)  lay the answers before each House of the Parliament.

[nuclear tests]